Media Thread, page-959

While it is true that the uptake of Painchek technology may not be as widespread globally as it could be, it's important to note that the company is still relatively new and making strides in expanding its reach. Additionally, the stalled uptake in some areas may be due to a variety of factors, including market conditions and competition, rather than a reflection of the technology's effectiveness.

It's also worth noting that the share price of a company is affected by a range of factors, including market sentiment, investor confidence, and company performance, and cannot be solely attributed to the uptake of a particular technology.

Overall, Painchek technology has shown promise in improving patient care and streamlining assessment processes, and the company continues to work towards expanding its reach and improving uptake.